Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.829 USD | +2.36% | -6.95% | +15.62% |
Apr. 26 | VolitionRx Limited Announces Board Changes | CI |
Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
Financials (USD)
Sales 2024 * | 3.63M | Sales 2025 * | 16.48M | Capitalization | 68.07M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -32M | EV / Sales 2024 * | 16.3 x |
Net cash position 2024 * | 8.9M | Net Debt 2025 * | 18.4M | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
-2.04
x | P/E ratio 2025 * |
-2.57
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.1% |
Latest transcript on VolitionRx Limited
1 day | +2.36% | ||
1 week | -6.95% | ||
Current month | -7.88% | ||
1 month | +14.80% | ||
3 months | -26.64% | ||
6 months | -5.78% | ||
Current year | +15.62% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 21-01-31 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Martin Faulkes
CHM | Chairman | 80 | 11-10-05 |
Guy Innes
BRD | Director/Board Member | 67 | 11-10-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.829 | +2.36% | 83,603 |
24-05-09 | 0.8099 | +10.04% | 166,177 |
24-05-08 | 0.736 | +2.22% | 174,260 |
24-05-07 | 0.72 | -7.61% | 304,804 |
24-05-06 | 0.7793 | -12.53% | 182,092 |
Delayed Quote Nyse, May 10, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.62% | 68.07M | |
-27.67% | 9.87B | |
-17.30% | 2.73B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- VNRX Stock